BackAnbio Biotechnology Class A Ordinary Shares Overview

Anbio Biotechnology Class A Ordinary Shares Net Tangible Assets

Anbio Biotechnology Class A Ordinary Shares's net tangible assets is $30M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$30.16M
↑ 75.41% YoYΔ $12.96M vs prior year quarter

Peer trimmed avg / median

Loading

Anbio Biotechnology Class A Ordinary Shares Net Tangible Assets History

Loading

Anbio Biotechnology Class A Ordinary Shares vs. peers: Net Tangible Assets Comparison

Loading

Anbio Biotechnology Class A Ordinary Shares Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Anbio Biotechnology Class A Ordinary Shares (NNNN) FAQ

The latest net tangible assets for NNNN is $30M as of December 2025. That compares with $17M in the prior-year period — up 75.4% year over year. Investors often review this figure alongside Anbio Biotechnology Class A Ordinary Shares's historical trend and sector peers before judging valuation or financial health.

Over the past year, NNNN's net tangible assets moved from $17M to $30M — a 75.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Anbio Biotechnology Class A Ordinary Shares's operating scale or balance-sheet position.

A net tangible assets figure of $30M for NNNN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NNNN's net tangible assets ($30M), review year-over-year change from $17M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers